| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 724562 | 11-(3'Aminopropylidene)-5,6-dihydro-5-oxo-2,3-dimethoxy-6-methyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline | 0.0235234559682127 | 0.34436 |
| NSC 726902 | Null | 0.0235234559682127 | 0.22767507 |
| NSC 727985 | NSC 708781 incorporated in micelles, 0.55% (w/w) of drug | 0.0235234559682127 | 0.40047563 |
| NSC 730460 | 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate | 0.0235234559682127 | 0.43958452 |
| NSC 731155 | 6-(3-Aminopropyl)-5,6-dihydro-5,11-dioxo-3-nitro-11H-indeno[ 1,2-c]isoquinoline Hydrochloride salt | 0.0235234559682127 | 0.31110805 |
| NSC 742146 | Bisarylpurine | 0.023523455968213 | 0.27269989 |
| NSC 745957 | 2-Benzylthio-4-chloro-N-[imino(3,4,5-trimethylpyrazol-1-yl)methyl]-5-methylbenzenesulfonamide | 0.023523455968213 | 0.24266091 |
| NSC 750039 | Null | 0.023523455968213 | 0.17805676 |
| NSC 755417 | Null | 0.023523455968213 | 0.41672996 |
| NSC 758376 | 2-(1-(2-fluorophenylsulfonyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide | 0.023523455968213 | 0.2749657 |